HUB Investment Partners’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-12,622
| Closed | -$286K | – | 573 |
|
|
2024
Q4 | $286K | Sell |
12,622
-3,392
| -21% | -$76.8K | 0.01% | 410 |
|
|
2024
Q3 | $394K | Sell |
16,014
-1,070
| -6% | -$26.3K | 0.02% | 331 |
|
|
2024
Q2 | $395K | Sell |
17,084
-266
| -2% | -$6.15K | 0.02% | 310 |
|
|
2024
Q1 | $418K | Sell |
17,350
-141
| -0.8% | -$3.4K | 0.02% | 302 |
|
|
2023
Q4 | $402K | Sell |
17,491
-3,938
| -18% | -$90.6K | 0.03% | 262 |
|
|
2023
Q3 | $436K | Sell |
21,429
-701
| -3% | -$14.3K | 0.07% | 148 |
|
|
2023
Q2 | $517K | Buy |
22,130
+1,350
| +6% | +$31.5K | 0.09% | 128 |
|
|
2023
Q1 | $484K | Sell |
20,780
-2,307
| -10% | -$53.7K | 0.1% | 121 |
|
|
2022
Q4 | $581K | Sell |
23,087
-1,458
| -6% | -$36.7K | 0.13% | 61 |
|
|
2022
Q3 | $648K | Sell |
24,545
-799
| -3% | -$21.1K | 0.2% | 85 |
|
|
2022
Q2 | $732K | Sell |
25,344
-3,012
| -11% | -$87K | 0.23% | 87 |
|
|
2022
Q1 | $977K | Sell |
28,356
-6,963
| -20% | -$240K | 0.23% | 81 |
|
|
2021
Q4 | $1.55M | Sell |
35,319
-302
| -0.8% | -$13.2K | 0.36% | 71 |
|
|
2021
Q3 | $1.81M | Buy |
35,621
+6,105
| +21% | +$310K | 0.43% | 62 |
|
|
2021
Q2 | $1.54M | Buy |
29,516
+3,337
| +13% | +$174K | 0.41% | 65 |
|
|
2021
Q1 | $1.2M | Buy |
26,179
+13,341
| +104% | +$610K | 0.35% | 79 |
|
|
2020
Q4 | $500K | Buy |
+12,838
| New | +$500K | 0.23% | 93 |
|